The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Open accessPublished version of a preprint
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index; 38 of the 52 sources its claims cite were checked for support.
Abstract
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research. They consist of a checklist of information to include in publications describing in vivo experiments to enable others to scrutinise the work adequately, evaluate its methodological rigour, and reproduce the methods and results. Despite considerable levels of endorsement by funders and journals over the years, adherence to the guidelines has been inconsistent, and the anticipated improvements in the quality of reporting in animal research publications have not been achieved. Here, we introduce ARRIVE 2.0. The guidelines have been updated and information reorganised to facilitate their use in practice. We used a Delphi exercise to prioritise and divide the items of the guidelines into 2 sets, the "ARRIVE Essential 10," which constitutes the minimum requirement, and the "Recommended Set," which describes the research context. This division facilitates improved reporting of animal research by supporting a stepwise approach to implementation. This helps journal editors and reviewers verify that the most important items are being reported in manuscripts. We have also developed the accompanying Explanation and Elaboration (E&E) document, which serves (1) to explain the rationale behind each item in the guidelines, (2) to clarify key concepts, and (3) to provide illustrative examples. We aim, through these changes, to help ensure that researchers, reviewers, and journal editors are better equipped to improve the rigour and transparency of the scientific process and thus reproducibility.
Overview
CoChat Summary
TL;DR
ARRIVE 2.0 updates the 2010 ARRIVE reporting guidelines for in vivo animal research, reorganising 21 items into the “ARRIVE Essential 10” minimum set and a “Recommended Set” for research context. The revision used a Delphi exercise and an accompanying Explanation and Elaboration document to improve transparency, methodological scrutiny, and reproducibility.
Key findings
- Despite endorsement by more than a thousand journals, adherence to the original ARRIVE guidelines has been inconsistent: randomisation was reported in only 30%–40% of publications, blinding in approximately 20%, sample size justification in less than 10%, and all basic animal characteristics in less than 10%.
- ARRIVE 2.0 divides items into two prioritised groups with no ranking within each group: the “ARRIVE Essential 10” as the minimum requirement and the “Recommended Set” to describe research context; together they comprise items 1–21.
- New additions include inclusion and exclusion criteria, protocol registration, and data access in line with the FAIR Data Principles; the accompanying Explanation and Elaboration document explains each item’s rationale, clarifies key concepts, and provides illustrative examples.
- A Delphi exercise with experts from 19 countries ranked items by relative importance for assessing reliability of research findings, and the revised guidelines were road tested with researchers preparing manuscripts describing in vivo studies.
Methods
- Guideline revision by an international working group with expertise across life sciences, including funders, journal editors, statisticians, methodologists, and academic/industry researchers.
- A Delphi exercise with external stakeholders from 19 countries provided feedback, suggested new items, and ranked items by importance; demographics and full methods/results are in Supporting Information S1 Delphi and S1 Data.
- Following BioRxiv publication, the revised guidelines and E&E were road tested with researchers preparing in vivo manuscripts; this study is presented in Supporting Information S1 Road Testing and S2 Data.
Limitations
- The paper states two main factors limit the impact of ARRIVE: the extent to which editorial and journal staff actively enforce reporting standards, and insufficient awareness among researchers and organisations of the consequences of incomplete reporting; it cites a PLOS ONE randomised controlled trial where requesting a completed ARRIVE checklist alone failed to improve disclosure.
- The paper also states that the level of resource required from journals and editors likely prohibits implementation of all ARRIVE items.
- The paper does not present a formal limitations section for ARRIVE 2.0 itself; evident from the text, the main article reports no empirical evaluation of ARRIVE 2.0’s effect on reporting quality, and road-testing details are placed in Supporting Information rather than the main text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 3 Not valid · 2 Not checked · 20 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“animal characteristics (all basic characteristics reported in less than 10% of publications)”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Could not verifycites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol sourceExperimental — accuracy not yet measured
The paper’s Abstract (page unavailable) reports how often publications described randomisation, blinded outcome assessment, sample-size calculations and conflicts of interest. Searches for animal characteristics, including species, strain, sex, age and weight, found no passage giving a figure for publications reporting all basic characteristics. The less-than-10% claim therefore cannot be verified from our copy. (LLM, conf=0.72)
- Partly supportedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results report poor reporting of animal-related details among 47 preclinical studies, and the Discussion says basic information such as sex and age was routinely omitted. But the Results’ 9% figure refers to allocating animals to experimental groups and to housing and husbandry—not to the proportion of publications reporting all basic animal characteristics. The claimed less-than-10% figure for all characteristics is therefore not established by our copy. (LLM, conf=0.83)
- Disputedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. sourceExperimental — accuracy not yet measured
Table 3 (Results > Items; page unavailable) reports that all experimental-animal characteristics were fully reported in 15.4% and 29.5% of papers in ARRIVE-supporting journals in 2009 and 2015, respectively, and 10.9% of papers in non-supporting journals in 2015. These figures exceed the claimed threshold of less than 10%. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“randomisation (reported in only 30%–40% of publications)”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Partly supportedcites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol sourceExperimental — accuracy not yet measured
The paper reports randomisation in 35.7% of CAMARADES publications from 2009–2010, which falls within the claimed range. But the Abstract also reports lower overall rates in its datasets (20%, 24.8%, and 14.4%), so 30%–40% is not supported as an unqualified rate for publications generally. (LLM, conf=0.88)
- Disputedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results report randomization as a composite item in 23% of the 47 studies, not 30%–40%. They separately report that 47% used the term “randomization”; neither measure falls within the claimed range. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Disputedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results (Sub-items; page unavailable) state that randomization (sub-item 6b) was reported in more than 50% of the papers studied, contrary to the claimed 30%–40%. The Discussion’s lower 13%–20% figure concerns reporting the allocation method, not reporting randomization itself. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, despite this level of support, recent studies have shown that important information as set out in the ARRIVE guidelines is still missing from most publications sampled.”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Supportedcites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol source
The indexed Abstract reports that 797 of 1,168 sampled publications (68%) did not report any of four important risk-of-bias measures. It also notes that reporting remained low even after journals endorsed the ARRIVE guidelines. No page number is supplied in our copy. (LLM, conf=0.90)
- Supportedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. source
The Results (page not provided) report that papers published after ARRIVE was introduced still reported fewer than 50% of the assessed reporting items. The Discussion (page not provided) concludes that reporting was generally incomplete, including for details important to assessing study validity. The finding concerns the paper’s sample of preclinical animal studies. (LLM, conf=0.91)
- Supportedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. source
The Discussion, under “Adherence to reporting guidelines remains low despite journal support,” says reporting standards in the sampled papers were low and that reporting of important study-design indicators—randomization, blinding, sample-size calculation, and data handling—remained low. This supports the claim that important ARRIVE information was missing from most sampled publications. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research.”
- Also stated in: § Why good reporting is important · plain
“In an attempt to improve the reporting of animal research, the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were published in 2010.”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Abstract
What the sources say
- Not checked — no full text of the sourcecites [21] C Kilkenny, 2010, Improving bioscience research reporting: ARRIVE-ing at a solution, Lab Anim source
- Not checked — no full text of the sourcecites [22] C Kilkenny, 2010, Animal research: reporting in vivo experiments: the ARRIVE guidelines, J Gene Med source
- Supportedcites [23] C Kilkenny, 2010, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, PLoS Biol source
In “Improving the Reporting of Animal Experiments—The ARRIVE Guidelines,” the authors say they led the initiative to produce ARRIVE guidelines for reporting animal research. “Improved Reporting Will Maximise the Output of Published Research” states that the guidelines were developed to improve the information provided in publications. This 2010 paper presents the guidelines, although it notes that drafting began at a June 2009 meeting. (LLM, conf=0.91)
- Supportedcites [24] C Kilkenny, 2010, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research., Journal of Pharmacology & Pharmacotherapeutics. source
In “Improving the reporting of animal experiments—the ARRIVE guidelines,” the authors say they developed ARRIVE as guidelines for reporting animal research. The paper describes a draft agreed in 2009, while its References list the ARRIVE guidelines’ publications in 2010; thus 2010 is supported as the year the original guidelines appeared, not the year work on them began. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [25] C Kilkenny, 2010, Animal Research: Reporting In Vivo Experiments: the ARRIVE guidelines, J Physiol source
- Supportedcites [26] C Kilkenny, 2010, Animal Research: Reporting In Vivo Experiments: the ARRIVE guidelines, Exp Physiol source
The Funding section identifies this text as the ARRIVE guidelines and says they are excerpted from a 2010 publication titled “Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research.” The publication details in the ITEM RECOMMENDATION section place this version in Experimental Physiology in 2010 (pp. 842–844). (LLM, conf=0.92)
- Supportedcites [27] JC McGrath, 2010, Guidelines for reporting experiments involving animals: the ARRIVE guidelines, Br J Pharmacol source
The Background describes ARRIVE as a newly generated set of guidelines filling a gap in reporting animal studies. The Abstract calls them a new set of guidelines for reporting research involving animals, and the 2010 references establish the date. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [28] C Kilkenny, 2011, Animal Research: Reporting In Vivo Experiments-the ARRIVE Guidelines, J Cereb Blood Flow Metab source
- Not checked — no full text of the sourcecites [29] C Kilkenny, 2012, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, Vet Clin Pathol source
- Partly supportedcites [30] C Kilkenny, 2012, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, Osteoarthritis Cartilage sourceExperimental — accuracy not yet measured
The section on improving the reporting of animal experiments says ARRIVE was developed to improve reporting and describes a draft agreed at a working-group meeting in June 2009. The References list ARRIVE guideline publications from 2010, but the paper does not establish that the guidelines were originally developed in 2010 rather than first drafted in 2009. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Why good reporting is important · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“blinding (reported in only approximately 20% of publications)”
§ The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research > Why good reporting is important
What the sources say
- Supportedcites [11] MR Macleod, 2015, Risk of bias in reports of in vivo research: a focus for improvement, PLoS Biol source
The passage reporting results for in vivo research from five leading UK institutions states that 201 of 1,165 publications (17.3%) reported blinding, reasonably described as approximately 20%. The paper also reports different rates in other samples, so this figure applies to that cohort rather than all publications. (LLM, conf=0.90)
- Partly supportedcites [31] MT Avey, 2016, The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results (page not available) identify blinding as a core reporting item and say that none of the core items were reported more than 40% of the time in the 47 studies assessed. Our copy does not give an approximately 20% figure for blinding, and the sample was limited to preclinical studies of acute lung injury treated with mesenchymal stem cells, not publications generally. (LLM, conf=0.78)
- Partly supportedcites [32] V Leung, 2018, ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS ONE. sourceExperimental — accuracy not yet measured
The Results (Sub-items; page unavailable) identify blinding as a poorly reported sub-item, and the Discussion says its reporting remained low. Our copy does not give a blinding-specific figure of approximately 20%, so the numerical part of the claim is not verified. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
11 more claims · 6 with their cited sources checked
Create a free account to see all 40 claims and to verify the 3 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although there have been debates on sample size calculation and power analysis [3,4,6], the need for an appropriate sample size calculation has become a major trend in research [1,2,7-11].”
From Sample size determination and power analysis using the G*Power software (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reporting frameworks that have proven durable in other domains, such as CONSORT for randomized trials,40 MIAME for microarray experiments,41 and ARRIVE for animal research,42 emerged from sustained, community-based development, and turned informal good practice into structured requirements only once the underlying science had matured enough to support them.”
From Designing reproducible large-language-model-assisted scientific analyses (2026) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some of the highly adopted checklists include CONSORT (Consolidated Standards of Reporting Trials) [19,20], ARRIVE (Animal Research: Reporting of In Vivo Experiments) [13,14], and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [21].”
From Open Science 2.0: Towards a truly collaborative research ecosystem (2023) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“To ensure that the recommendations are as clear and useful as possible to the target audience, this document was road tested alongside the revised guidelines with researchers preparing manuscripts describing in vivo research [13].”
From Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0 (2020) · cites this paper as [13]
In the citing paper
“All experiments were designed and reported according to the Animal Research: Reporting of In Vivo Experiments guidelines (Percie du Sert et al., 2020).”
From Complex bioactive nanofibrous dura mater repairs traumatic brain injury (2026) · cites this paper as Percie du Sert et al., 2020
Citations
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Self-citationImproving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Self-citationAnimal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Self-citationRaise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000411 · Cited by 2,677
Self-citationAnimal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Self-citationThe preregistration revolution
Nosek, B. A., Ebersole, C. R., DeHaven, A. C., & Mellor, D. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708274114 · Cited by 1,998
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Guidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437
Cited by
Items 5,401–5,500 of 6,206
Vachadze, N., Khetsuriani, R., Pailodze, M., Arabuli, M., Shvangiradze, E., Sultanishvili, T., Kharabadze, M., Gogiberidze, A., & Pruidze, N. (2026) · Georgian Biomedical News · doi:10.52340/gbmn.2026.01.01.172
Gemenetzis, G., Papalois, A., Smyrniotis, V., Arkadopoulos, N. F., & Vassiliu, P. (2026) · Cureus · doi:10.7759/cureus.110708
Ibrahim, M., Stadnicka, K., Bednarczyk, M. F., & Grochowska, E. (2026) · BMC Genomics · doi:10.1186/s12864-026-12983-6
Asano, H., & Nishimoto, S. (2026) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbag082
Hovsepyan, A. S., Petrosyan, T., Saghatelyan, L., Paronyan, M. H., Koloyan, H. O., Hayrapetyan, H., Tsaturyan, A., & Avetisyan, S. V. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02017-9
Leptadenia hastata and caffeic acid attenuate hepatic glycogen depletion in Type 2 diabetic rats
Mailabari, Y. H., Omoaghe, A. O., & Olaniyi, K. S. (2026) · Comparative Clinical Pathology · doi:10.1007/s00580-026-03815-w
Yao, M., Liu, J., Dong, Y., Li, M., Yuan, Y., Wang, B., Liu, W., Zhang, B., Dong, R., Sun, X., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-57741-6
Development of a Rat Arterial Aneurysm-Endoleak Model for EVAR Sac Filling Material Research
Fan, J., Chai, K.-J., Zhang, H., Wang, X., Wang, Y., Li, Z. J., & Zhang, L. (2026) · Journal of Endovascular Therapy · doi:10.1177/15266028261454345
Yogev, B. E., Levi, G., Efroni, N., Sintov, A. C., Todder, D., Zohar, J., & Cohen, H. (2026) · Scientific Reports · doi:10.1038/s41598-026-56757-2
Panaampon, J., Ogawa, T., Shiota, A., & Okada, S. (2026) · Transgenic Research · doi:10.1007/s11248-026-00500-0
Karaca, Ç., Koç, O., Çetinkaya, M. A., Çam, S. B., Er, N., & Korkusuz, P. (2026) · BMC Oral Health · doi:10.1186/s12903-026-08941-z
Gunawan, E., Lesmana, R., Gunawan, H., ROSDIANTO, A. M., Lubis, L., Pandia, V., & Purba, A. (2026) · F1000Research · doi:10.12688/f1000research.181861.1
Liu, D., Ouyang, H., Wei, X., Chen, Z., Zhang, S., & 闫福岭 (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1818232
Qin, T., Liang, J., Ya, W., Long, Y., Wu, J., Meng, D., & Gan, F. (2026) · PeerJ · doi:10.7717/peerj.21436
Barraco, A., Gustin, M., Noël, G., Grosgogeat, B., & Lafon, A. (2026) · International Journal of Dentistry · doi:10.1155/ijod/5542019
Design and validation of a biomechanics device for preclinical arthrofibrosis models
Carstens, M. F., Meißner, N., Weintraub, M. T., Pichurin, O., Morrey, M. E., Sánchez‐Sotelo, J., Berry, D. J., Thaler, R., & Abdel, M. P. (2026) · Bone and Joint Research · doi:10.1302/2046-3758.156.bjr-2025-0620.r1
Pérez-Allende, L. D. C., Meza, S. H., Viveros-Contreras, R., Martínez, A. J., Arroyo-Helguera, O. E., Corona-Morales, A. A., & Bolado‐García, V. E. (2026) · Obesities · doi:10.3390/obesities6030042 · Cited by 1
Nagata, A., Mukaibo, T., Munemasa, T., Nodai, T., Saito, Y., Kondo, Y., Hosokawa, R., & Masaki, C. (2026) · Odontology · doi:10.1007/s10266-026-01470-9
Marlier, Q., Boreux, A., Rives, A., Mosca, D., Michaux, H., Schmitz, L., Attali, P., Silvente, S., Lefebvre, P. P., Malgrange, B., et al. (2026) · Frontiers in Stroke · doi:10.3389/fstro.2026.1802085
Sun, H., Wang, Y., Lai, S., Zhu, X., Cheng, L., Liang, M., Bi, X., Zeng, H., & Zhu, J. F. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-26-00245
Haynes, K. A., Pandey, R. S., Doud, E. H., Cope, Z. A., Little, G. J., Williams, S.-P., Nepali, U., Quinney, S. K., Nagar, A., Charbe, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.16.731973
Ward, J. L., Goodman, J., Blondel, T., Zdyrski, C., Manson, E., Merodio, M. M., Lamers, R. P., Allenspach, K., Guillot, E., & Mochel, J. P. (2026) · Journal of Veterinary Internal Medicine · doi:10.1093/jvimsj/aalag119
IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis
Upadhyay, R., Orellana, A. G., Tsokos, G. C., & Bhargava, R. (2026) · Arthritis & Rheumatology · doi:10.1002/art.70260
Rodrigues, R. S., Armada‐Moreira, A., Gómez-Acero, L., Ribeiro, F. F., Mouro, F. M., Sebastião, A. M., Ciruela, F., Aso, E., & Xapelli, S. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70466
Batı, B., Vuran, N. E., DÜNDAR, A., Basmacı, G., & Çelik, İ. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2026.2692587
Hyperpolarized MRI Detects Increased [1‐ 13 C]Pyruvate Metabolism in Early Liver Regeneration
Kjærgaard, U., Lund, A., Bertelsen, L. B., Hansen, E. S. S., Andersen, K. H., Ringgaard, S., Nielsen, C. M., Mortensen, F. V., & Laustsen, C. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70340
Deng, P., Wu, X., Liu, Y., Song, B., Liu, X., Yang, X., Luo, Y., Peng, J., Li, H., Wang, Z., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03931-y · Cited by 1
da SILVA, F., Cappellaro, G. L., Zazula, M. F., Dahleh, M. M. M., Prigol, M., Guerra, G. P., Lc, F., Bertolini, G. R. F., Torrejais, M. M., Naliwaiko, K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9999084/v1
Maxwell, J., Joyner, J. A., Norton, J. E., Knapp, W., Wang, I., Swaminathan, G., Monslow, M. A., & Citron, M. P. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2689208
la Calle, C. N., Careaga, L., Malan‐Müller, S., Río-García, Á. D., Trueba, Y., de Biedma‐Elduayen, L. G., Morales‐Puerto, N., Vidal, R., Wiman, Å., Erhardt, S., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70549
Wippel, D., Heidler, J., Gratl, A., Lobenwein, D., Gaeth, C., Hinck, D. C., Kluckner, M., Abram, J., Spraider, P., Martini, J., et al. (2026) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004903
Asirvatham, R. (2026) · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi · doi:10.33715/inonusaglik.1786460
Sulamanidze, G., Albina, K., & Никишин, Д. В. (2026) · Cureus · doi:10.7759/cureus.111360
Zaccaron, R. P., Barbieri, R. T., Casagrande, L. D. R., Lima, I. R., Martins, G., da Costa, C., Cardoso, I. A., Pieri, E. D., Guarita-Souza, L. C., Machado‐de‐Ávila, R. A., et al. (2026) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.70102
Corona, A. C., Harrison, H., Hopper, R. G., Smith, A. L., Rogers, C. M., Cook, C. L., Salzman, M. M. H., Peterson, K. D., Hall, N. J., & Mowat, F. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-59321-0
Çil, N., Balseven, H. M., Kızıldağ, A., Akyer, Ş. P., Neşet, G., Mete, E., Önder, C., Enli, Y., & Mete, G. A. (2026) · Meandros Medical And Dental Journal · doi:10.69601/meandrosmdj.1812033
Dwiharyani, Y., Olivia, I., Santoso, P., & Ilmiawati, C. (2026) · Comparative Exercise Physiology · doi:10.1163/17552559-bja10100
Serrano-Ramirez, M. S., Rasgado‐Toledo, J., Medina-Sánchez, D., Trujillo-Villarreal, L. A., Carranza‐Aguilar, C. J., & Garza‐Villarreal, E. A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111805
Engman, V., Lamon, S., & Mason, S. A. (2026) · Steroids · doi:10.1016/j.steroids.2026.109823
Kimmeswenger, I., Feješ, A., Somoza, V., Šebeková, K., & Lieder, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1857562
Essa, L. A., Altalhi, R., Alshehri, N. M., Mohamed, A. A.-R., Alosaimi, M. E., Noreldin, A. E., Khamis, T., Rashwan, E. K., & Abd‐Elhakim, Y. M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1820042
Bishop, M. S., Pustovit, R. V., Jufar, A. H., Lane, D. J. R., May, C. N., Ayton, S., Plummer, M. P., Ow, C. P. C., & Lankadeva, Y. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-59679-1
Salinas, P., Villarroel, F., Astorga, L., Cerdá, P., Rojas, E., & Maulén, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135715
Loss of lncRNA H19 impairs neonatal cardiac regeneration
Hilbold, E. A., Costa, A., Cushman, S., Fuchs, M., Jansen, K., Selich, A., Huang, C.-K., Haubner, B. J., Thum, T., & Bär, C. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00002.2026
Li, B., Yang, J., Cai, M., Yee, S. K., Carlson, D. M., Smoot, R. L., Baker, D. J., & Ilyas, S. I. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.24.734341
Liu, W. T., Tang, Y. T., Ding, W., Cao, J., Guo, C., & Xiao, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.23.734114
Vučićević, T., Papić, M., Papic, M. V., Vuletic, M., Mišić, A., Zdravković, D., Rakic, J., Vucicevic, K., Kovačević, M. M., Popovic, M., et al. (2026) · Dentistry Journal · doi:10.3390/dj14070393
Mangiacotti, M., Fumagalli, M., & Sacchi, R. (2026) · RENDICONTI LINCEI · doi:10.1007/s12210-026-01431-y
Wang, G., Han, J., Jia, S., Fan, S., Zhu, Z., Guo, S., Ahmad, N., Zhang, B., Song, Y., & Zhang, L. Y. (2026) · Antioxidants · doi:10.3390/antiox15060773
Aranda, M. D. C., de Andrés, P. J., Villanueva‐Saz, S., & Martínez, M. D. L. Á. J. (2026) · Veterinary Sciences · doi:10.3390/vetsci13070619
Hu, W., Tong, H., Zhu, M., Wang, H., Huang, X., Fan, S., Guo, G., Ismail, M., Zhao, L., Li, X., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70518
Acar, B., Çelik, A., Kocamaz, A. H., Kişi, Ö. N., Varman, A., Alkan, S., Fındık, S., Kılınç, İ., Şentürk, M., & Küçükkartallar, T. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07929-w
Alsou’b, D. F. B., Kepe, E., Hajna, Z., Ulrich, G., Pintér, E., & Tékus, V. (2026) · Scientific Reports · doi:10.1038/s41598-026-58562-3
Carotid body mitochondria exhibit normal oxygen affinity despite COX4I2 enrichment
Swiderska, A., Murphy, M. P., Galli, G. L. J., & Trafford, A. W. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.09.005 · Cited by 1
Takahashi, M., Ookubo, A., Yoshimura, T., Toyonaga, T., Saotome, K., Yoshihama, T., Jisaka, M., Sakamaki, T., Nakamura, K., Sakai, K., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-59944-3
Paternal obesity programs adverse serum lipid and lipoprotein profiles in rat offspring
Le, T. T. K., Andreani, G. A., Mahmood, S., Ramalingam, L., & Rideout, T. C. (2026) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174426100610
“White and Clear” (WaC): A tunable hydrophilic tissue clearing strategy for multi‐species 3D imaging
Llorente, V., Fernandez-Cortes, E., Sanderson, D., Romero, J. B., Gil‐Jaurena, J., Bernaldo-de-Quirós, E., Riobóo, R. J. J., Correa‐Rocha, R., Izquierdo‐Barba, I., Samaniego, R., et al. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20260029
Cauich-Olan, A. G., Zapata-Escalante, K. A., Pineda-Alegría, J. A., Marin-Tun, C. G., Torres-Acosta, J. F. J., Sandoval-Castro, C. A., Aguilar-Marcelino, L., & Mancilla-Montelongo, G. (2026) · Journal of Helminthology · doi:10.1017/s0022149x26101783
Immune Mechanisms and Translational Study Design in Viral Vaccine Development
Lim, S., & Martina, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135790
Liu, R., 贺庚贤, Pan, J., Fu, S., Lin, S., Zhang, X., Qiu, S., Zhu, Z., Zhu, X., & Feng, J. (2026) · Brain Sciences · doi:10.3390/brainsci16070691
Ginkgo biloba extract as a retinal protective agent: a systematic review of preclinical experiments
Shi, N., Li, J., Yan, Y., Jin, Y., Zhang, W. L., Shang, M., Wu, X., Cui, Y., & Liang, L. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12251-6
Donnelley, M., Smith, R., Cmielewski, P., Reyne, N., Pirakalathanan, P., Eikelis, N., Nilsen, K., Louise, J., Barratt, K., Logan, J. M., et al. (2026) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70219
Hou, J., Wen, C., Lin, K., Xing, L., Yu, X., Liu, W., Li, X., & Li, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10038039/v1
Wiegmann, F. L., & Ford, N. L. (2026) · Research Square · doi:10.21203/rs.3.rs-8768201/v1
Zhou, Y., Guo, X., He, H., Yang, Y., Zhang, Y., Feng, H., & Li, Z. K. (2026) · Nutrients · doi:10.3390/nu18132124
Tsuboi, N., Tsuboi, K., Tsubokura, S., Miyasho, T., ITAMI, T., & Takeuchi, M. (2026) · Intensive Care Medicine Experimental · doi:10.1186/s40635-026-00936-y
Pellissier, L. P., Dudas, A., Caire, E., Kuku, A. H. A., Marchand, O., Azzopardi, N., Elseedy, H., Jugnarain, V., Vacher, H., Piégu, B., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10129888/v1
Zhang, Y., 邹红玲, Deng, S., Zou, L., Xia, M., & Tao, L. (2026) · Oncology Reports · doi:10.3892/or.2026.9158
Song, C., Wu, X., Chen, C., Wang, X., Liu, F., Liu, Z., Chen, F., & Wang, H. (2026) · Biomedical Chromatography · doi:10.1002/bmc.70530
Wu, X., Zhang, Y., Yang, Q., Xue, L., Guo, Y., Li, L., Liu, C., Jin, M., Pan, G., Men, J., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70567
Kumar, K., Kumar, P., Kumar, P., & Sharma, D. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01923-8
Gunes, Y., Günay, E., Yılmaz, N., Deveci, E. İ., Civelek, D. Ö., Anlaş, C., Bakırel, T., Üstüner, O., Coşkun, A. S., Oran, D. S., et al. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05904-y
Experimental Evaluation of Hepatoprotective Activity in Male Albino Rats
Nirapure, D. P. S. C. (2026) · International Journal of Research & Technology · doi:10.64882/ijrt.v14.i3.1570
Filfilan, W. M., & El‐Beeh, M. E. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01910-z
Abdel-Hafeez, E. H., Abdel-Fatah, M. M., Sanadeki, M., Nasr, M. M. S. A., Hafez, S. M., & Rabou, R. A. M. A. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00838-8
Tian, Y., Wang, C., Zhu, Q., Guo, L., Bai, X., Aikebaier, G., Cui, X., Wu, Z., & Liu, J. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1860375
Increasing the number of extinction sessions suppresses context-specific sensitization in mice
Rauhut, A. S. (2026) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000881
Chen, L. X., Pan, Y. L., Cao, X., Peng, W., Zhu, C., Ye, J., & Xie, Z. (2026) · Scientific Reports · doi:10.1038/s41598-026-60940-w
Teichert, M., Gull, S., Herrmann, K., Urbach, A., Frahm, C., Chung, H., Gaser, C., Holthoff, K., Reichenbach, J. R., Witte, O. W., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.124.039816
Zhou, Y., Zhang, Z., Zhang, Y., Yuan, T., Lassance‐Soares, R. M., Tipparaju, S. M., Wu, C. Y., & Lee, R. H. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70575 · Cited by 1
Spoelder, M., van Donkelaar, I., Wolf, C. J. H., Bright, Y., Docq, S., Middelman, A., & Homberg, J. R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736000
Félix, F. B., Maravilha, A. P. S. D. C., Beltrami, V. A., Resende, L. C., Santos, A. L. D. C., Vago, J. P., Queiroz‐Junior, C. M., Galvão, I., Guimarães, P. P. G., Costa, V. V., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70555
Zaccarelli‐Magalhães, J., Udo, M. S. B., Smith, D. J., Langman, J., Matuguma, L. H., Gomes, G. N., Rodriguez, P., Husan, A., Zhang, Q., Kevil, C. G., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70535
Nishikawa, M., Uchiyama, Y., Nakamura, K., Kato, M., Yamada, K., Torii, S., Kanda, T., Yamashita, T., Horigane, S., Takemoto‐Kimura, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-60407-y
Orel, V. B., Diedkov, A. G., Vé, O., Tovstolytkin, A. I., Dasyukevich, O. I., Kovalevska, L. M., Galkin, A. Y., & Rykhalskyi, O. (2026) · Cancers · doi:10.3390/cancers18132145
HIF1α Attenuates Doxorubicin‐Induced Cardiotoxicity by Activating TEX264‐Associated ER‐phagy
Wang, X., Zhan, G., Li, J., Yang, X. L., Wen, Y., Tang, Y., Zhang, P., Xia, Y., & Yang, X. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047158 · Cited by 1
Fang, Y., Wu, K., Yan, S., Chen, Z., & Zhu, X. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.6c00113
Zhang, Y., Wang, X., Tan, N., Zhang, Y., Zong, Y., Chen, F.-K., Liu, J. M., & Liu, L. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70560 · Cited by 1
Aoshima, K., Miyazaki, N., Goto, T., & Heishima, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.03.735423
Chen, Z., Yu, X., Tang, L., Zhao, Y., Yang, X. D., Su, R., & Xiong, Z. (2026) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001858
Zhou, L., Huang, R., Liang, J., Sun, W., Xia, H., Zhou, X. Y., Zhong, X., Li, W., & Wang, Z. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1853850
Wei, J.-X., Mao, H., Mo, H., Chen, Y., Deng, E., Zhong, A., Tang, X., Liu, S., Zheng, S., Liao, H., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70477
Vásquez, M. R. S., Alvarado-García, P. A. A., Jara-Aguilar, R., Gavídia-Valencia, J. G., Ruiz-Reyes, S. G., & Penadillos, R. A. R. (2026) · Molecules · doi:10.3390/molecules31132378
Acute Toxicity of Three Synthetic Cannabinoids: First In Vivo Preclinical Study
Filipiuc, S. I., Solcan, C., Tamba, B.-I., Filipiuc, L.-E., Bild, V., Ababei, D. C., Stanciu, G. D., Gogu, M.-R., Urîtu, C. M., Foia, C. I., et al. (2026) · Molecules · doi:10.3390/molecules31132365
Clavel-Pérez, P. I., Phillips-Farfán, B. V., Camacho, L., Calderón‐Garcidueñas, A. L., & Carvajal, K. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1845387
Petrunich-Rutherford, M. L. (2026) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-026-00614-1
The application of geometric morphometric analysis in the study of bovine ovarian morphology
Fares, M. A., & Rahmoun, D. E. (2026) · Theoretical and Applied Veterinary Medicine · doi:10.32819/2026.14009
Kitaguchi, D., Vix, M., Forgione, A., Lapergola, A., Oda, T., & Marescaux, J. (2026) · Surgical Endoscopy · doi:10.1007/s00464-026-13060-5
Photoperiod Regulates Cardiac Oxidative Stress via the Keap1/Nrf2 Pathway in Striped Dwarf Hamsters
Xu, J., Wang, M., Wang, C.-L., Zhao, X., Xue, H., Wu, M., Chen, L., Fan, C., & Wang, Z. (2026) · Journal of Zoology · doi:10.1111/jzo.70140
Metadata
- Authors
- Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., MacCallum, C. J., Macleod, M., Pearl, E. J., Petersen, O. H., Rawle, F., Reynolds, P., Rooney, K., Sena, E. S., Silberberg, S. D., Steckler, T., & Würbel, H.
- Affiliations
- National Centre for the Replacement Refinement and Reduction of Animals in Research (GB)
- Queen Mary University of London (GB)
- Taylor and Francis (United Kingdom)
- University of Bristol (GB)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Imperial College London (GB)
- Liverpool School of Tropical Medicine (GB)
- University of Southampton (GB)
- University of Tasmania (AU)
- AstraZeneca (United Kingdom) (GB)
- Prioris.ai (Canada) (CA)
- Hindawi (United Kingdom) (GB)
- University of Edinburgh (GB)
- Cardiff University (GB)
- Medical Research Council (GB)
- University of Florida (US)
- The University of Sydney (AU)
- National Institute of Neurological Disorders and Stroke (US)
- Janssen (Belgium) (BE)
- University of Bern (CH)
- ORCID
- Percie du Sert, Nathalie
- Hurst, Viki
- Ahluwalia, Amrita
- Alam, Sabina
- Avey, Marc T.
- Browne, William J.
- Clark, Alejandra
- Cuthill, Innes C.
- Dirnagl, Ulrich
- Emerson, Michael
- Garner, Paul
- Holgate, Stephen T.
- Howells, David W.
- Karp, Natasha A.
- Lazic, Stanley E.
- MacCallum, Catriona J.
- Macleod, Malcolm
- Pearl, Esther J.
- Petersen, Ole H.
- Rawle, Frances
- Reynolds, Penny
- Rooney, Kieron
- Sena, Emily S.
- Silberberg, Shai D.
- Steckler, Thomas
- Würbel, Hanno
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-07-14
- Volume
- 18
- Issue
- 7
- Pages
- e3000410
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC7360023
- OpenAlex
- W4236357753
- Cited by
- 5,939
- References
- 60
- Citations by year
- 2026: 1201 · 2025: 1307 · 2024: 994 · 2023: 920 · 2022: 823 · 2021: 579 · 2020: 106
- FWCI
- 520.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Biology (publishedVersion, public-domain)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, public-domain)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › Academic Writing and Publishing
- Keywords
- ARRIVE guidelines, animal research reporting, in vivo experiments, research transparency, reproducibility, reporting checklist, methodological quality, peer review, journal editorial policy
- MeSH terms
- Animals, Guidelines as Topic, Animal Experimentation, Checklist, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-24, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-24 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.